Home » Topics » Nephrology, BioWorld Science

Nephrology, BioWorld Science
RSS

First patients randomized in phase IIa trial of SER-150 in diabetic nephropathy

Aug. 17, 2015

Proteon initiates second phase III study of vonapanitase

Aug. 17, 2015

Daiichi Sankyo discloses compounds for hyperphosphatemia

Aug. 13, 2015

Relypsa signs new patiromer agreements

Aug. 12, 2015

FDA accepts NDA for ZS-9 in hyperkalemia

July 30, 2015

Phase III extension studies show long-term benefit of NX-1207 in BPH

July 29, 2015

EMA committee recommends approval of Fexeric

July 27, 2015

Vidasym's phosphate binder VS-505 enters phase I/II trial

July 23, 2015

Gilead patents MAP3K5 inhibitors

July 20, 2015

ErepoXen increases hemoglobin levels to therapeutic range in phase II trial

July 16, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 25, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...